Pubblicazioni

Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial

2023 - JOURNAL OF CLINICAL LIPIDOLOGY

Witztum, Joseph L; Gaudet, Daniel; Arca, Marcello; Jones, Alan; Soran, Handrean; Gouni-Berthold, Ioanna; Stroes, Erik S G; Alexander, Veronica J; Jones, Richard; Watts, Lynnetta; Xia, Shuting; Tsimikas, Sotirios

New and Emerging Therapies for Dyslipidemia

2022 - ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Zambon, Alberto; Averna, Maurizio; D'Erasmo, Laura; Arca, Marcello; Catapano, Alberico

Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)

2021 - CURRENT ATHEROSCLEROSIS REPORTS

D'Erasmo, L.; Bini, S.; Arca, M.

Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials

2020 - CURRENT ATHEROSCLEROSIS REPORTS

Fogacci, F.; Norata, G. D.; Toth, P. P.; Arca, M.; Cicero, A. F. G.

Clinical and biochemical features of different molecular etiologies of familial chylomicronemia

2018 - JOURNAL OF CLINICAL LIPIDOLOGY

Hegele, Ra; Amanda J., Berberich AJ; Ban, Mr; Wang, J; Digenio, A; Alexander, Vj; DâErasmo, L; Arca, M; Jones, A; Bruckert, E; Stroes, Es; Bergeron, J; Civeira, F; Witztum, Jl; Gaudet, D